I.B.N. Savio

I.B.N. Savio (Istituto Biochimico Nazionale Savio) is a long-established Italian pharmaceutical company headquartered in Pomezia, Italy. Founded in 1924, the company specializes in the development, manufacturing, and commercialization of pharmaceutical products, with a particular focus on respiratory and musculoskeletal therapeutic areas. In addition to its proprietary product portfolio, which includes well-known brands like Breva and Aircort, I.B.N. Savio operates as a Contract Development and Manufacturing Organization (CDMO) for various dosage forms, including sterile liquids and solids. In 2022, the company was acquired by the Spanish Labiana Group, integrating its operations into an international healthcare platform. The company continues to serve as a key supplier in the Italian market while expanding its global reach through its parent organization.